Related Experiment Videos
Labetalol in hypertensive emergencies
The Medical Journal of Australia
|April 8, 1978
Summary
Intravenous labetalol, an alpha- and beta-blocker, was ineffective for severely hypertensive patients already on other medications. This treatment approach is not recommended for hypertensive emergencies in such cases.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Critical Care
Background:
- Hypertensive emergencies require prompt and effective blood pressure reduction.
- Labetalol is an antihypertensive agent with combined alpha- and beta-blocking properties.
Purpose of the Study:
- To evaluate the efficacy of intravenous bolus labetalol in severely hypertensive patients.
- To determine the utility of intravenous labetalol in managing hypertensive emergencies in patients on concurrent antihypertensive therapy.
Main Methods:
- Six severely hypertensive patients received intravenous bolus labetalol.
- Blood pressure response was monitored following administration.
Main Results:
- Intravenous labetalol administration resulted in unsatisfactory blood pressure control in all six patients.
- No patient achieved adequate blood pressure reduction with this intervention.
Conclusions:
- Intravenous labetalol is not a useful treatment for hypertensive emergencies in patients already receiving other antihypertensive agents.
- The combined alpha- and beta-blocking effects of labetalol via intravenous bolus were insufficient in this patient population.